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Abstract: Medical device software development organisations are bound by regulatory 
requirements and constraints to ensure that developed medical devices will not harm 
patients. Medical devices have to be treated as complete systems and be evaluated in this 
manner. Instead of manufacturers having to ensure compliance to various regulatory 
standards individually, the authors previously developed a medical device software process 
assessment framework called MDevSPICE® that integrates the regulatory requirements 
from all the relevant medical device software standards. MDevSPICE® was developed in a 
manner that suits plan-driven software development. In order to improve the usability of 
MDevSPICE in agile settings, we extended the assessment approach. The hybrid 
assessment approach described here, combines the MDevSPICE® based process 
assessment method with steps for prioritization of improvement needs through value stream 
mapping, and enabling process improvement through the use of KATA. This approach 
integrates agile methods into the medical device software development process whilst 
adhering to the requirements of the regulatory standards. This paper describes the 
implementation of the approach within four organisations that develop software in line with 
medical device regulations.  
Keywords: MDevSPICE, medical device software development, medical standards, agile software 
development 
1. INTRODUCTION 
Increasingly, safety-critical software systems are affecting our everyday living as more and 
more software is embedded into safety critical systems such as cars, trains, airplanes, and 
healthcare systems which include medical devices. In order to ensure the safety of such systems 
international standards have been developed. In order to market a medical device within a 
particular region, the manufacturer has to satisfy a number of regional regulatory requirements. 
To assist software development organisations in the medical device domain and to achieve 
regulatory compliance, the authors have previously developed an integrated framework of 
medical device software development best practices called MDevSPICE® [1]. MDevSPICE® 
integrates generic software development best practices with medical device standards’ 
requirements enabling robust software process assessments to be performed against an 
organisation’s current software development practices.  
MDevSPICE® was originally designed to be used with both traditional waterfall and V-model 
lifecycle models. These software development life cycle models are plan-driven, rigid and 
sequenced which make MDevSPICE®’s usage limited for companies which wish to adopt agile 
software development approaches.  In order to extend the capability and usage of 
MDevSPICE®, agile practices were integrated into the assessment approach. 
A standard MDevSPICE® assessment approach includes evaluation of 23 processes at the base 
practice level. In this paper, we describe the hybrid assessment approach, which includes value 
stream mappings. Additionally, it integrates agile practices into the reporting phase of an 
MDevSPICE assessment so that such practices can be provided to organisations within the 
findings report instead of purely plan driven improvement recommendations. Afterwards, we 
prioritise these recommendations to enable a focus to be provided to the process improvement 
implementation through the use of KATA [2]. We discuss how the hybrid assessment approach 
was implemented in four companies, three of which are from medical domain and one of them 
is a software development company that is planning to develop software that could in the future 
be classified as a medical device.  
In Section 2, we provide an overview of the regulatory requirements medical device software 
development companies face before they are able to market their devices. In Section 3, we 
describe the structure of the MDevSPICE® framework. Section 4 outlines the challenges 
associated with using MDevSPICE® lessons learned when validating the framework in expert 
reviews and in industry through MDevSPICE® pilot assessments. In Section 5, we present the 
literature review and how the perception of the use of agile software development in medical 
device software development has changed. In Section 6, we introduce the hybrid assessment 
approach for medical device software development companies. In Section 7, we present the 
implementation of the approach in four companies. We provide our conclusions and future 
research in Section 8.   
2. REGULATIONS 
In order to place a medical device on the market it is necessary to satisfy the regulatory 
requirements for that region. Two significant markets for medical devices are the USA and the 
European Union. Within the USA the FDA are responsible for issuing and managing medical 
device regulation. The FDA provides a number of regulatory and guidance documents in 
relation to medical devices, including the Code of Federal Regulation Title 21, Chapter I, 
Subchapter H, Part 820 [3]. In the European Union (EU), the European Commission defines 
directives that are then overseen by competent authorities within each of the member states. 
There are a number of medical device directives: the Active Implantable MDD (AIMDD) 
90/385/EEC [4]; the general Medical Device Directive (MDD) 93/42/EEC [5]; the In-vitro 
Diagnostic (IVD) MDD 98/79/EC [6]; and an amendment which applies to all three directives 
2007/47/EC [7].  
IEC 62304:2006 [8] is the foundational medical device software standard. This standard 
describes medical device software lifecycle processes and outlines software safety 
classification. IEC 62304 is an important standard for medical device software developers as it 
is the only standard that provides information for medical device software based on the worst 
case scenario of software failure. As risk management is important for medical device software 
development IEC 62304 should be used along with the general medical device risk management 
standard ISO 14971 [9] and IEC 80002-1 [10]. IEC 80002-1 provides guidance on the 
application of ISO 14971 for software development. Additionally, within the medical device 
domain it is important to have a Quality Management System (QMS) in place. For example, 
the QMS for the European medical device domain is ISO 13485 [11]. The QMS requirements 
of ISO 13485 need to be adhered to in order to market a medical device in Europe. As ISO 
13485 does not specifically focus upon software requirements, it may be used to support the 
safe design of medical device software in conjunction with IEC 62304 [8].  
IEC 62304 defines three medical device software safety classifications: Class A; Class B; and 
Class C. Failure of software that is of safety Class A will result in no injury or damage to the 
health of a patient. In the case of failure of software with a safety classification of B, non-serious 
injury may occur. Software with a safety Classification of C has the highest risk as in the case 
of failure death or serious injury may occur happen. Depending on the functionality of software 
within the medical device, the software safety classification may vary from the overall medical 
device safety class.  
IEC 62304 considers a medical device to include a software component as rather than being a 
complete medical device system. Consequently, IEC 62304 does not consider a medical device 
to be formed completely of software, but rather that there are also other electronics or hardware 
components that together with the software form a complete medical device system. Therefore, 
system level requirements are not included within IEC 62304 but instead within IEC 60601-1 
[12] which is a medical device system level standard. Additionally, given the increasing 
importance of human factors and usability within the medical device industry, organizations 
should also adopt  IEC 62366 [13], which outlines usability engineering requirements for the 
medical devices.  
As a result of an amendment to the medical device directives [7] software systems that perform 
the functionality of a medical device (as opposed to being a component of an overall medical 
device) could be defined as a medical device in their own right. However, until recently 
international medical device standards did not address standalone software as a medical device. 
To address this IEC 82304-1 [14] was published in October 2016. IEC 82304-1 applies to 
healthcare software that is designed to operate on IT platforms without dedicated hardware, 
e.g., mobile applications on tablets and phones. 
If a company is planning to market a medical device in the US, they need to register their 
product with the FDA. The FDA have issued an overview of their guidance documents for 
developers of medical device software [15]. There are four guidance documents: the FDA 
Guidance on Premarket Submissions [16]; the FDA Guidance on Off-The-Shelf Software Use 
in Medical Devices; the FDA General Principles of Software Validation [17]; and Guidance on 
MMAs [18] to provide clarity for MMA developers in terms of what types of applications will 
be regulated and how. In order to market a medical device in Europe, organizations need to 
comply with the following directives: the Active Implantable MDD; the general Medical 
Device Directive; the In-vitro Diagnostic MDD; and 2007/47/EC.  
 
3. MDevSPICE® FRAMEWORK 
As outlined in the previous section organisations developing medical device software must 
adhere to a large number of regulatory requirements and international standards if they wish to 
market their device. In order to reduce the demanding and costly overhead associated with 
preparing for regulatory audits, we developed MDevSPICE® [1, 19]. MDevSPICE® integrates 
software requirements from the various international medical device standards and guidance 
documents (described in Section 2) with best practices for software and systems development 
into a single reference source. The capability of an organization’s medical device software 
processes may then be assessed using this reference source. MDevSPICE® was designed to 
assist organisations to develop medical device software through adopting either a traditional 
waterfall model or a V-model lifecycle model. However, such development lifecycles are very 
rigid, prescribed and sequenced, which presents problems in relation to introducing 
requirements changes throughout development. 
As stated previously, IEC 62304 only relates to software that is a component of an overall 
medical device. Therefore, IEC 62304 only includes software lifecycle processes, and 
additional processes are required when the software developed is the complete medical device 
system. Consequently, when software is the entire medical device systems development 
processes also need to be considered. These systems development  processes were derived from 
ISO/IEC 12207:2008 [20]. Additionally, Risk Management and Quality Management 
requirements from ISO 14971 and ISO 13485 were also added to MDevSPICE® as both are 
foundational standards for medical device development. MDevSPICE® consists of 23 processes 
[1]. There are ten system lifecycle processes, 8 software lifecycle processes and 5 support 
processes. MDevSPICE® has been validated through both international expert review and 
industrial trials and was founded upon IEC TR 80002-3, which is the Process Reference Model 
for IEC 62304 [21]. The development of IEC TR 80002-3 was led by the authors in 
collaboration with the international medical device standards working group for IEC 62304. 
Upon successful completion of international expert reviews, MDevSPICE® was validated 
through pilot assessments in 10 medical device software development organizations over two 
years. 
MDevSPICE® was designed to enable full lifecycle coverage in a plan-driven manner. It 
provides the requirements of all associated medical device standards in one place. This 
framework integrates software engineering best practices so that safer medical device software 
may be developed through adopting MDevSPICE®.  
 
4. The CHALLENGES ASSOCIATED with USING MDevSPICE® 
Formal models like CMMI [22] and ISO/IEC 15504 [23] are used to promote maturity and 
capability in software processes. In the literature, there are very few studies discussing the 
challenges and successful implementations of integrating agile and formal software process 
improvement models [24-26]. Literature discussions are mostly shaped to answer the question 
of why agile and formal process improvement models do not contradict each other. Previously, 
it was thought by the commercial software development community that formal process 
improvement models and agile are at odds with each other [27, 28]. According to the Software 
Engineering Institute (SEI) what caused the perception of the relationship between Agile and 
CMMI to be like “oil and water” may be attributed to the presentation of extreme examples of 
both sides by early adopters, therefore providing inaccurate information about them and their 
misusages [27].  
In a study including 40 agile experts, composed of researchers and academics, the participants 
classified each CMMI component as either: (1) in conflict with; (2) of no consequence to; or 
(3) being supportive of agile methods in general. The results showed that the differences 
between the agile and formal process communities are beginning to be better articulated and 
better understood. It was stated that although there are significant differences between both 
sides, they could work together [29].  
The authors have performed many MDevSPICE® assessments within medical device software 
development companies and have experienced challenges using MDevSPICE® in Agile 
Software Development environments. MDevSPICE® is designed for high-risk, safety critical 
systems which in the case of a software failure, could result in harm to human life. To reduce 
the risk associated with software failures, MDevSPICE® favors upfront planning. This is one 
of the major contradictions of MDevSPICE® with agile software development that agile 
methods favor an adaptive and exploratory approach through accepting that it is difficult to get 
requirements completely understood up-front. For example, signing off both system and 
software requirements before development commences is in conflict with the product backlog 
grooming practice in Scrum which allows you to dynamically update and re-prioritize backlog 
items.  
Another challenge that the authors have observed was associated with the recommendations 
given to organisations after process assessment. As a descriptive model, MDevSPICE® does 
not prescribe how to perform base practices within a specific context, however provides 
guidance with possible outputs of the practices. These outcomes again, are derived from formal 
software development life cycle models with recommendations being plan driven and formal. 
Therefore, more effective ways to implement software needed to be integrated with 
MDevSPICE®. 
Additionally, companies found that MDevSPICE® was excellent at highlighting gaps in current 
software development processes but that the plan-driven recommendations provided often 
increased the overhead associated with development. Therefore, they really would like to have 
been provided with more flexible recommendations that could be implemented in a much more 
efficient manner. Likewise, companies also found that MDevSPICE® tended to focus more 
upon providing guidance in relation to strategies and plans that need to be put in place rather 
than providing more practical recommendations as to how this could be achieved. 
5. AGILE USAGE in the MEDICAL DOMAIN 
This section has been taken out of the pre-print version due to copy right issues. The full 
paper could be found at https://onlinelibrary.wiley.com/doi/full/10.1002/smr.1929.  
 
6. The HYBRID APPROACH 
The hybrid assessment approach we discuss within this paper for medical device software 
development has two principal activities as shown in Figure 1: studies in theory and studies in 
the field. These two studies are fed from each other. In theory, we are developing an integrated 
agile MDevSPICE®, by analyzing 1st and 2nd generation agile software development approaches 
at a practice level and mapping these practices with MDevSPICE® base and specific practices. 
Thus, we ensure both agility and conformance to regulatory standards. The studies in the field 
start with basic MDevSPICE® based assessments to identify strengths and issues within the 
companies. The basic MDevSPICE® assessment process includes assessment planning, 
execution and reporting phases.  This process extends the MDevSPICE® assessment process by 
including both prioritization and implementation of the prioritized recommendations. A value 
stream mapping is performed as part of the prioritization stage to observe where the bottlenecks 
are between the process blocks. The prioritized recommendations are implemented through the 
use of the KATA technique [49] in an iterative manner until all recommendations are complete. 
The following sections provide details of these activities. 
 
Figure 1 Representation of the Hybrid Assessment Approach 
6.1. Studies in Theory 
One of the major components of our hybrid assessment approach is the “agile practices 
repository” that includes a bilateral mapping of agile practices against MDevSPICE®’s base 
and specific practices. The purpose of the mapping is to understand which of the MDevSPICE® 
base and specific practices could be fulfilled by adopting associated agile practices (for 
recommendations) and what additionally needs to be done to satisfy regulatory requirements. 
We aim to extend the applicability of MDevSPICE® in companies which follow an agile 
software development life cycle. We selected eXtreme programming [50], Scrum [51], 
DevOps[52], Lean [53], Kanban [54], Disciplined Agile Delivery (DAD) [31] and Scaled Agile 
Framework (SAFE) [55] as the source of the agile practices that we adopt. This selection was 
made to cover: small and large scale agile adoption (DAD and SAFE); fundamental agile 
methods (XP, Scrum, KanBan); and new paradigms (DevOps, Lean). For example, in Table 1 
we provide a mapping between the primary practices of XP and MDevSPICE®’s base practices. 
Table 1 The Mapping between Primary Practices of XP and MDevSPICE®’s Processes and Base 
Practices 
Primary Practices of XP MDevSPICE® Process MDevSPICE® Base Practice/s 
Sit Together PRO.1 Project Planning PRO.1.BP6: Define needs for 
experience, knowledge and skills.  
PRO.1.BP10: Establish project plan.  
Pairing and Personal Space PRO.1 Project Planning PRO.1.BP6: Define needs for 
experience, knowledge and skills.  
Weekly Cycle PRO.2 Project Assessment and 
Control 
PRO.2.BP2: Monitor project interfaces 
PRO.2.BP3: Report progress of the 
project 
PRO.2.BP4: Perform project review 
Quarterly Cycle PRO.2 Project Assessment and 
Control 
PRO.2.BP2: Monitor project interfaces 
PRO.2.BP3: Report progress of the 
project 
PRO.2.BP4: Perform project review 
Whole Team PRO.1 Project Planning PRO.1.BP6: Define needs for 
experience, knowledge and skills.  
Informative Workspace Could be PRO.1 Project Planning Not Exist 
Energized Work Could be PRO.1 Project Planning Not Exist 
Pair Programming DEV.4 Software Unit 
Implementation and Verification 
DEV.4.BP1: Implement the software 
units.  
Slack PRO1.Project Planning PRO.1.BP4: Define and maintain 
estimates for project attributes.  
PRO.1.BP8: Define project schedule.  
Ten Minute Build DEV.5 Software Integration and 
Integration Testing 
DEV.5.BP1: Integrate software units 
into software items. 
DEV.5.BP2: Verify that software 
integration follows integration strategy.  
DEV.5.BP3: Develop tests for 
integrated software items. 
Continuous Integration DEV.4 Software Unit 
Implementation and Verification 
DEV.5 Software Integration and 
Integration Testing 
DEV.4.BP4: Verify software units. 
DEV.5.BP1: Integrate software units 
into software items.  
Test First 
Programming/Continuous 
Testing 
DEV.4 Software Unit 
Implementation and Verification 
DEV.5 Software Integration and 
Integration Testing 
DEV.4.BP4: Verify software units.  
DEV.5.BP3: Develop tests for 
integrated software items.  
DEV.5.BP4: Test integrated software 
items in accordance with the 
integration plan and document the 
results.  
Incremental Design ENG.2 System Requirements 
Analysis 
DEV.1 Software Requirements 
Analysis 
ENG.2.BP1: Establish system 
requirements.  
ENG.2.BP5: Evaluate and update 
system requirements.  
DEV.1.BP1: Define and document all 
software requirements.  
Story DEV.1 Software Requirements 
Analysis 
DEV.1.BP1: Define and document all 
software requirements.  
 
6.2. Studies in the Field 
MDevSPICE® Based Process Assessment: MDevSPICE®, has been validated in the medical 
device industry through pilot assessments during the past four years [1, 19]. An MDevSPICE® 
assessment is performed to grasp the current condition of the company and identify problems 
and issues regarding the medical software development life cycle. The basic MDevSPICE® 
assessment process includes assessment planning, execution and reporting phases as described 
below. In the assessment planning phase, we decide upon the scope of the assessment. In other 
words which project/s to assess and the processes to be included in the assessment. 
Additionally, the logistics are agreed in terms of the dates that the assessment will take place 
on and the company staff that will participate within the assessment.  
In the execution phase, we perform interviews with the participants that were nominated for 
each process. One interview is performed for each process area with normally two assessors 
and at least one person from the company being present within each interview. During each 
interview, the assessors ask the company employees a comprehensive set of scripted questions 
that were derived from the base practices of each process by the assessment team in advance of 
the onsite assessment. The assessors also ask additional related questions that arise during the 
course of the interview to glean more information about the companies’ processes. In addition 
to the question and answer interview session, as we are assessing medical device organisations 
who have to produce evidence that they have followed their processes throughout the 
development lifecycle, we also request them to provide us with specific evidence of their 
software development process such as requirements documents, design artifacts and tools that 
are in actual use to support the responses to their interview questions.  
In the reporting phase, upon completion of the onsite execution stage, the assessment team go 
offsite and prepare a findings report by working together to agree upon the assessment findings 
including strengths, issues and recommendations. The recommendations both include agile and 
plan driven practices. The assessment team then return back to the assessed company and 
present the findings report to all participants and this acts as the first step towards improvement. 
The next is to prioritize the recommendations provided in the findings report. 
A) Prioritization: After the reporting phase, we obtain a list of the issues and problems that 
needs to be solved to deliver products in a more efficient manner. We prefer to keep these items 
on an Improvement Backlog which are prioritized and dynamic like a product backlog. 
Value Stream Mapping:  The reporting phase is followed by the value stream mapping study 
(VSM). The purpose of the value stream mapping is to visualize bottlenecks, redundancies and 
gaps in the value delivery system [56]. Therefore, it is very beneficial to perform this at the 
prioritization stage so that crucial bottlenecks can be highlighted and recommendations selected 
first that will enable the process to be improved in the most efficient order to remove these 
bottlenecks. VSM is one of the lean practices used in the Toyota Production System and was 
introduced by Rother and Shook [57]. The value stream is the flow of work from a customer 
request to the fulfillment of that request [49]. The value stream mapping is the process of 
identifying various process blocks at a decent level of detail within the product delivery. We 
utilize the value stream of a product or feature to specify where to direct our attention for 
process improvement. To run a value stream exercise, we interview people with responsibilities 
for different parts of the software development lifecycle who can authorize the process changes 
required to achieve an effective future-state value stream. We use three metrics within the value 
stream mapping study as shown in Table 2: Lead Time (LT), Process Time (PT) and Percent 
complete and accurate (%C/A) [49].  
Table 2 Metrics that are used in Value Stream Mapping 
Metric  Description 
Lead Time (LT) Total time to complete a process block with all interruptions 
Process Time (PT) Actual time to complete a process block without any interruptions 
Percent Complete and 
Accurate (C/A %) 
The proportion of time a process receives something from an upstream 
process that does not require rework 
   
B) Improvement KATA: One of the first steps that must be taken in software process 
improvement is to decide how the changes will be identified, agreed upon and adopted in the 
existing system and more importantly how the improvement will be continuous after the 
assessment team (change agents) leave the company. The technique that we selected for this 
purpose is called Improvement KATA [2]. The KATA idea, which comes from Japanese 
martial arts, means habits or patterns of thinking that are being conducted by an individual and 
practiced every day [2]. Improvement KATA is a general-purpose framework including a set 
of practices for reaching goals where the path to the goal is uncertain. Improvement KATA 
provides an experimental approach with a 4 step pattern: 1) Understand the direction or 
challenge, 2) Grasp the current condition, 3) Establish the next target condition and 4) Iterate 
towards the target condition [49]. In process improvement, the experimental approach for 
finding the right practices and figuring out the ways to implement them is very important so 
that the companies do not over invest in a solution that will not work for them. The challenge 
of investing in the right improvement practices for the right time could only be achieved with 
the help of an experimental approach. 
Following an MDevSPICE® based process assessment, we introduce companies to the 
Improvement KATA framework and the KATA document templates to be used in the process.  
Some parts of this section have been taken out of the pre-print version due to copy right 
issues. The full paper could be found at 
https://onlinelibrary.wiley.com/doi/full/10.1002/smr.1929.  
Improvement and Re-assessments: We implement the changes in an iterative and incremental 
way and follow the progress. Besides, to ensure the conformance to regulatory standards, we 
re-assess the software projects. 
7. IMPLEMENTATION of the APPROACH via ACTION RESEARCH 
We have implemented the Hybrid Assessment Approach which includes the following sub-
sections described above: software process assessments based on MDevSPICE® (Section 6.2, 
Part (A)), prioritizations and value stream mappings (Section 6.2, Part (B)) and Improvement 
KATA approach (Section 6.2, Part (C)). Even though we have started improving the processes of 
the companies, the project is not in the re-assessment phase yet.  
Based on the characteristics of this research, the best qualitative approach that suits the needs 
of the research is action research which associates theory and practice. In the action research, 
the practice is informed by the research and the research is informed by the practice 
synergistically [58]. “Action research is an iterative process involving researchers and 
practitioners acting together on a particular cycle of activities, including problem diagnosis, 
action intervention, and reflective learning” [58]. The purpose of implementing the proposed 
approach is to show the applicability of this approach in the medical device software 
development industry. Thus, we implemented the research in four different companies three of 
which are from medical device development domain and one of them is a software development 
organization that is planning to develop software that could in the future be classified as a 
medical device and therefore also wants to implement MDevSPICE® as a process improvement 
framework.  
7.1. Overview of the Companies and Planning 
The selected companies approached us with the purpose of improving their software processes 
while ensuring regulatory requirements. After initial negotiations, they agreed to be a part of 
the study. In paragraph below, we briefly describe each participating company. 
Company A develops medical applications for iOS, Android, Windows 8 and Web Browser. It 
was formed in 2011 and since 2012, it has been developing Medical Device Software. The 
products that they developed are classified as Class B based on IEC 62304:2006. It is a small 
company based in Ireland and including 7 people whom are developers, testers, a product 
manager and clinicians. Company B develops software that is currently not safety critical but 
the organisation has demands placed upon them from their industry as it has to be always 
accurate, reliable and consistent. Company B is based in Ireland and employs 50 people. 
Company C develops mobile and web applications to assist patients who are recovering from 
injury or operations or are dealing with chronic pain. The products that they develop are 
classified as Class B based on IEC 62304:2006. It is based in Ireland and 10 people work in the 
company. Company D develops medical device software applications for usage by patients, 
with an objective to improve patient engagement with healthcare practitioners. It is a large-
scale company employing more than 150 people across three main offices in Ireland, Poland 
and the US. The medical device software products that they develop are mostly classified as 
Class B based on IEC 62304:2006. 
In the planning phase, for each organization we have decided the type of the project and number 
of the processes that will take place in the process assessment, the dates of the assessment and 
the staff that will be included in the assessment.   
Initially, we planned 1 full day of low level assessments for the major software life cycle 
processes with each company, 2 full days of off-site study for evaluation of the findings and 
report preparation and a further half day for the onsite findings’ briefing presentation (for each 
company). We selected 10 processes to be assessed which were Project Planning, Project 
Monitoring, Stakeholder Requirements, System Requirements Analysis, System Architectural 
Design, Software Requirements Analysis, Software Architectural Design, Software Unit 
Implementation and Testing, Software Integration and Testing, Software System Testing. Prior 
to assessments, we defined a detailed set of assessment questions based on MDevSPICE® base 
practices.  For value stream, prioritization and KATA studies, we prepared the templates.  
7.2. Implementation of the Action Research within the Companies 
We performed onsite visits to organisations for assessments. Two/three assessors were involved 
in each assessment, one asking scripted interview questions whilst the others took notes. In 
Table 3, we listed the roles of the interviewed staff, the total interview hours, types of assessed 
projects, and the assessed processes. The assessed processes diverged slightly from those 
planned for Companies A and B. Instead of the planned 10 processes, we actually assessed 7 
for Company A and 6 for Company B due to the time required to ask the large number of 
assessment questions combined with observing the supporting evidence, as we operated within 
a fixed time for the assessment. The assessments within Companies A and B process were then 
followed by prioritization (including value stream mapping studies) and as planned. However, 
due to limited number of the assessed processes, we couldn’t establish an overall view of the 
issues and problems in the projects within these assessments which had an significant impact 
on the prioritization phase.  
Table 3 Key Figures of Action Research Conduct 
 Company A Company B Company C Company D 
Interviewed Staff Chief Technical 
Officer 
Chief Technical 
Officer 
 
Chief Technical 
Officer 
Program 
Manager and 
and Chief Executive 
Officer 
 
and Software 
Architect 
Product 
Manager 
Total interview 
hours 
6 hours 6 hours 6 hours 11 hours 
Assessed project 
type 
Web and mobile 
based decision 
support tool 
Tool to monitor 
individual and team 
performance in real-
time 
Mobile and web 
based exercise  
guidance software 
 
A Platform 
which 
provides an 
infrastructure 
for a many 
medical 
device 
software 
applications 
which they 
also develop 
in-house.  
Number of the 
Assessed Processes 
7 6 23 23 
Assessed Processes  - Project Planning 
- Project Monitoring 
- Stakeholder 
Requirements 
Definition 
- Software 
Architectural 
Design 
- Software Unit 
Implementation and 
Testing 
- Software 
Integration and 
Testing 
- Software System 
Testing 
- Project Planning 
- Project Monitoring 
- Stakeholder 
Requirements 
Definition 
- System 
Requirements 
Analysis 
- System 
Architectural 
Design 
- Software 
Requirements 
Analysis 
 
All MDevSPICE 
processes. 
All 
MDevSPICE 
processes. 
 
 
With the experiences obtained from the Company A and Company B process assessments, we 
consequently changed the assessment plan, and decided to perform a holistic assessment with 
23 processes at a higher level (with less scripted questions). We reviewed all the assessment 
questions and defined 3 to 5 questions for each process which were more focused and open 
ended. For example, for system requirements analysis process, we asked the following four 
questions: 
– What types of component/interfaces do you have? 
– How do you define your system requirements? 
– Do you make use of a traceability matrix? 
– What challenges do you face in relation to the system requirements analysis process? 
For each process, we repeated the last question given above for each of the 23 processes, in 
order to figure out the challenges that they faced. 
In the value stream mapping studies, we discussed the major activities within the software 
development life cycle process, the lead times and percentage of rework required for these 
activities by the teams.  
For Company A and Company B, the assessment team went offsite and worked as a team to 
prepare the assessment findings reports. Within the findings phase, in addition to identifying 
strengths and gaps, we also listed improvement action suggestions to address the issues. Due to 
time scheduling difficulties it took more than two months for the assessment team to meet with 
Company A and B again on their premises to present the findings presentation. In order to 
achieve this in a more effective way, we changed the plan and extended our onsite stay for 
Company C and Company D, and presented the high-level findings for all 23 processes within 
the same week.  
The presentation of the findings and value stream mappings were followed by prioritization of 
the issues. We also presented how the improvement actions to resolves the identified issues 
could be implemented and presented the Improvement KATA approach to the development 
teams within each of the 4 companies. All 4 companies expressed excitement about the 
approach and liked the idea of implementing some initial actions to better determine if the 
suggested practices would work for them or not.  
7.3. Findings of the Action Research 
In this sub-section, we provide the findings of the action research in three parts: (a) common or 
specific issues that were found when performing the assessments, (b) an example of the 
implementation of the value stream mapping study and (c) results of the prioritization of the 
issues. 
(a) The Issues Found when Performing the Assessments 
Some parts of this section have been taken out of the pre-print version due to copy right 
issues. The full paper could be found at 
https://onlinelibrary.wiley.com/doi/full/10.1002/smr.1929.  
Below, we have discussed the issues that were either common or specific to the four companies 
and our suggestions for resolving the issues. The issues listed here were identified through both 
conducting interviews and observing project artifacts during the onsite visits. We asked 
detailed, pre-defined questions during the onsite interviews for each base practice in 
MDevSPICE® to the process owners.  
It was observed that Company A, B and C did not make use of formal project plans, project 
timelines or schedules. Progress against project objectives is not signed off.  Knowledge is not 
transferred efficiently between projects. In terms of estimation, there is no size estimation of 
software but effort estimation is performed in an Ad-Hoc way.  
We also found that customer involvement was quite limited within all the projects we assessed 
in the four companies. This creates accuracy and ambiguity problems in relation to captured 
requirements and as a result of this, rework was frequently required.  
We discovered in all four companies that third party functionality and the risks associated with 
that functionality at the software requirements, system requirements and software architecture 
stages were not taken into account and were often overlooked. Special attention is needed to 
ensure that third party functionality would not introduce safety risks into the medical device. 
In medical device development projects, most of the time hardware is part of the system and 
hardware decisions need to be made at the beginning of the projects, when the system 
requirements are not very clear. Therefore, system architecture decisions need to be verified 
not just with drawings but also through code. Proving the architecture with code was not a 
common practice in the projects we assessed.  
Automated tests play a significant role in terms of increasing the confidence of development 
teams with every change made progressing the development towards achieving higher quality 
software. For the three projects (A, B and C), the software and the system were manually tested. 
Automated unit and regression tests which are essential for continuous integration, have already 
started to be implemented in Company D as the goal is to achieve continuous delivery in the 
long term. 
(b) Value Stream Mapping 
In Figure 2, we provide an example of a value stream mapping study that we conducted within 
Company A. In this study, we looked at a feature’s life cycle at a deep level and identified LT, 
PT and C/A%. The VSM study showed that the process time for a feature to complete was 2 
weeks and 5 days whereas the lead time is 12.5 weeks. The result of the study made a significant 
impact on the group showing that there is a 10-week gap between Process Time and Lead Time. 
Upon analysis, the reason for the gap was attributed mostly to waiting rather than rework. After 
the study, requirements elicitation and analysis were selected as the first two areas to work.  
 Figure 2 Value Stream Mapping for the Delivery of a Feature in Company A 
(c) Prioritization 
For each company, we provided a list of the issues found during the assessment and presented 
these issues to relevant parties within the Companies. Given the issues and the differences 
between process times and lead times in value stream mapping, we were able to focus our 
attention to critical processes that needs to be treated first.  
Three highly connected processes in Company A, B and C which are stakeholder requirements 
definition, system requirement and software requirements, were selected as the first three 
processes to be focused. In parallel, it is aimed to establish automated unit test suites in parallel 
to other improvement studies.  
In Company D, we decided to direct our focus on improving the communication among 
feature/product teams within the program to achieve better results in the areas of requirements 
management and software architecture, given there might be common or conflicting 
requirements that will affect the software architecture at the program level. 
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(d) Improvement KATA: Here, we provide an example of utilizing the Improvement 
KATA technique in Company C.  
This section has been taken out of the pre-print version due to copy right issues. The full 
paper could be found at https://onlinelibrary.wiley.com/doi/full/10.1002/smr.1929.  
(e) Agile Recommendations 
This section has been taken out of the pre-print version due to copy right issues. The full 
paper could be found at https://onlinelibrary.wiley.com/doi/full/10.1002/smr.1929.  
8. CONCLUSION and FUTURE PLANS 
Medical device development organizations are seeking ways to be more flexible and adaptive, 
and ensure that they build safe and high-quality software and comply with the regulatory 
requirements. Based on both the safety classification and region they wish to market their 
medical device such organizations need to comply with different types of regulatory standards. 
In order to solve the complexity problem regarding compliance to different regulatory 
standards, we previously developed MDevSPICE®. Within this paper, we highlighted that 
whilst MDevSPICE® works well for companies developing software in a plan driven 
environment, the recommendations were difficult to implement within an agile development 
approach. Therefore, to solve this problem, we proposed a hybrid assessment approach. The 
approach includes the integration of agile practice recommendations with MDevSPICE® 
process assessments, then practicing value stream mappings as part of the prioritization phase, 
and then implementing suggested changes via the Improvement KATA technique. 
In this paper, we described the hybrid assessment approach for medical device companies and 
its implementation in four medical device software development companies. We performed 
onsite process assessments based on MDevSPICE®, analyzed their value streams, provided 
recommendations and prioritized improvement actions in terms of processes using action 
research. For these four companies, we identified and discussed which processes contained gaps 
and suggested improvement practices.  
Discussions with the assessed companies during the findings presentations reflected that based 
on the gaps and recommendations we presented to those companies, that the companies were 
keen to adopt this approach. Therefore, we feel that there is a need to build upon this research. 
In future studies with the companies, we will continue implementing agile specific 
improvement actions in an experimental way and periodically evaluating the progress. Value 
stream mapping studies will be repeated in three-month intervals to observe improvement in 
the lead times of the software development life cycle activities.  
In terms of the assessment process, we observed that it is more valuable within a short 
timeframe, to get a higher-level view of the project assessed across more processes, rather than 
completing a more detailed assessment across fewer processes. As the initial goal of the 
assessments performed was not for the purpose of preparing companies for regulatory audits 
but rather for the identification of gaps, and to recommend improvement needs, and for the 
prioritizations of the future actions. 
In terms of refining the hybrid assessment approach, an agile practices repository will be 
composed to provide two-way traceability between agile practices and MDevSPICE® base 
practices. We will be repeating this action research with other medical device software 
development companies and reflecting upon the lessons learned from the field studies relating 
to the hybrid assessment approach.  
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